Doctors News Hubb
Advertisement Banner
  • Home
  • News
  • Healthcare
  • Public Health
  • Paramedic
  • Nursing
  • Contact Us
No Result
View All Result
  • Home
  • News
  • Healthcare
  • Public Health
  • Paramedic
  • Nursing
  • Contact Us
No Result
View All Result
Doctors News Hubb
No Result
View All Result
Home News

Tobacco Use Has ‘Direct Impact’ on Risk for Chronic Rhinosinusitis

admin by admin
January 9, 2023
in News


The correlation between tobacco use and chronic rhinosinusitis was observed in both males and females and in patients with CRS with and without nasal polyposis.


“Although it has been postulated that tobacco use, as well as other environmental exposures, may contribute to chronic rhinosinusitis (CRS), the data remain limited,” Amarbir S. Gill, MD, and colleagues wrote.

For a study published in Clinical Otolaryngology, the researchers examined the impact of a history of tobacco use on the development of CRS.

“This study was inspired by what I felt was a knowledge gap in the literature surrounding a question that we, as ENTs, get asked by our patients,” Dr. Gill explained. “I wanted to understand whether a history of tobacco use impacted the risk for having chronic sinus disease.”

The researchers employed a case-control study design, using the Utah Population Database to search for adult patients with a diagnosis of CRS and a history of tobacco use. Enrolled patients also underwent endoscopic sinus surgery (ESS) between 1996 and 2018.

Tobacco Use Increases Risk for CRS

Dr. Gill and colleagues examined records for 200,370 patients in the final analysis, including 34,350 patients diagnosed with CRS and 166,020 controls.

The first diagnosis of CRS was made at a mean age of 43.9, and the percentage of patients with CRS with nasal polyposis was 58.3%. A history of tobacco use was observed in a significantly larger number of patients with CRS (19.6%) than in the matched controls (15%; P<0.001).

The correlation between a history of tobacco use and a CRS diagnosis was observed in both males and females and in patients with CRS with and without nasal polyposis (Table). The unadjusted OR for the risk for CRS in patients with a history of tobacco use was 1.38 (P<0.001).

More patients with CRS and comorbid asthma used tobacco (19.5%) compared with controls with asthma (15.0%; P<0.001).

“A history of tobacco use may signify an increased risk for the development of chronic sinus disease among patients undergoing sinus surgery compared with healthy controls,” Dr. Gill emphasized. “In a separate study, we found that a history of tobacco use may also increase the likelihood of needing revision sinus surgery.”

Role of Tobacco Cessation for Patients & Research

The results “emphasize the direct impact and relevance of tobacco use on patients with sinus disease,” Dr. Gill noted. “Providers can consider using the data to help educate patients on the relationship between tobacco and sinus disease and encourage and discuss tobacco cessation with them.”

He also pointed to areas of research interest. “Future research should focus on understanding whether tobacco cessation can positively impact sinus disease severity and symptoms.”

Beyond the impact of tobacco use, Dr. Gill noted that “there has been an increasing interest in the role of environmental pollutants and irritants on nasal and sinus inflammation, and I am hopeful this will yield novel insights into mitigation strategies as we learn more about how these irritants impact the health of our sinuses and nose.”



Source link

Advertisement Banner
Previous Post

The Nursing Shortage: Looking Ahead to 2023

Next Post

FDA approves Leqembi, Alzheimer’s drug from Eisai and Biogen

Related Posts

News

Treatment of Older Adults’ Constipation Caused by Opioids

February 7, 2023
News

Serious Illness: Advance Care Planning

February 6, 2023
News

Dual antiplatelet therapy discontinued 9 months after percutaneous coronary intervention associated with improved morbidity and mortality

February 5, 2023
News

#VisualAbstract: Aldosterone synthase inhibition reduced systolic blood pressure in patients with treatment-resistant hypertension

February 4, 2023
News

Risk of Severe COVID-19 Infection and Other SARIs in Preexisting Neuropsychiatric Conditions

February 3, 2023
News

Vitiligo Responding and Refractory Alopecia Areata During the Monotherapy With Tofacitinib

February 2, 2023
Next Post

FDA approves Leqembi, Alzheimer's drug from Eisai and Biogen

Recommended

Medical Fiction: Kyle and the Mistake

3 months ago

340B cuts must be undone after Supreme Court ruling: judge

4 weeks ago

Journalists intensify coverage of the harms of private equity 

1 month ago

Low dose aspirin not associated with congenital abnormalities

3 months ago

Why Make the Switch to a Meritech Automated Boot Scrubber?

3 months ago

© 2022 Doctors News Hubb All rights reserved.

Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.

Navigate Site

  • Home
  • News
  • Healthcare
  • Public Health
  • Paramedic
  • Nursing
  • Contact Us

Newsletter Sign Up.

No Result
View All Result
  • Home
  • News
  • Healthcare
  • Public Health
  • Paramedic
  • Nursing
  • Contact Us

© 2022 Doctors News Hubb All rights reserved.